We were honoured to host a delegation from Pfizer, led by Chief Vaccines Officer Dr. Annaliesa S. Anderson. 

During the visit, the parties exchanged insights on their respective missions, latest breakthroughs in biomedical research, and cutting-edge developments in healthcare innovation.  The engagement provided a dynamic platform for knowledge exchange and strategic dialogue centered on the future of healthcare innovation. 

We look forward to exploring future synergies with global industry partners to accelerate the clinical translation and real-world impact of our academic research.